Hata Yujiro S Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
9
Insider Sells Sum
$17.56M

Insider Activity of Hata Yujiro S

According to the SEC Form 4 filings, Hata Yujiro S, being in a position of

  1. President and CEO at IDEAYA Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 26338 shares for $985,397,
    over all time since 2023-12-15, has bought 0 shares, and sold 451338 shares for $18.54M.

Biography of Hata Yujiro S

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $985,3971100

Comparison of Insiders on Amount of Buys and Sells

2026-10-06SaleIDEAYA Biosciences, Inc.
IDYA
President and CEO
26,338
0.0283%
$37.41$985,397-7.43%
2024-05-16SaleIDEAYA Biosciences, Inc.
IDYA
President and CEO
34,433
0.0453%
$41.81$1.44M-31.44%
2024-05-15SaleIDEAYA Biosciences, Inc.
IDYA
President and CEO
83,856
0.112%
$42.90$3.6M-31.9%
2024-05-14SaleIDEAYA Biosciences, Inc.
IDYA
President and CEO
56,711
0.0746%
$41.61$2.36M-30.08%
2024-02-09SaleIDEAYA Biosciences, Inc.
IDYA
President and CEO
23,557
0.0351%
$45.54$1.07M-18.78%
2024-02-08SaleIDEAYA Biosciences, Inc.
IDYA
President and CEO
75,815
0.1121%
$45.15$3.42M-16.75%
2024-02-01SaleIDEAYA Biosciences, Inc.
IDYA
President and CEO
628
0.0009%
$45.00$28,260-15.63%
2024-01-16SaleIDEAYA Biosciences, Inc.
IDYA
President and CEO
62,739
0.0965%
$40.17$2.52M-5.95%
2024-01-12SaleIDEAYA Biosciences, Inc.
IDYA
President and CEO
12,261
0.0191%
$40.04$490,913-3.55%
2023-12-15SaleIDEAYA Biosciences, Inc.
IDYA
President and CEO
75,000
0.1165%
$35.03$2.63M+9.3%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.